Tags: Drug.

Tedisamil (37-dicyclopropylmethyl-99-tetramethylene-37-diazabicyclo-331-nonane) is an experimental class III antiarrhythmic agent currently being investigated for the treatment of atrial fibrillation. Tedisamil blocks multiple types of potassium channels in the heart resulting in slowed heart rate. While the effects of tedisamil have been demonstrated in both atrial and ventricular muscle repolarization is prolonged more efficiently in the atria.

Tedisamil.svg
ATC prefix
C01
ATC suffix
BD06
CAS number
90961-53-8
FDA UNII code
A5VAY2U3R8
IUPAC name
37-bis(cyclopropylmethyl)-37-diazaspiro[bicyclo[3.3.1]nonane-91'-cyclopentane]
PubChem
65825

Loading...

This page contains content from the copyrighted Wikipedia article "Tedisamil"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.